Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 3 studies | 20% ± 2% |
Insufficient scRNA-seq data for expression of NPPB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
heart | 99% | 57494.82 | 849 / 861 | 0% | 0 | 0 / 0 |
brain | 65% | 43.68 | 1705 / 2642 | 8% | 0.54 | 55 / 705 |
blood vessel | 56% | 55.00 | 743 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 30% | 6.53 | 78 / 258 | 24% | 5.23 | 55 / 230 |
stomach | 48% | 14.25 | 172 / 359 | 6% | 0.40 | 17 / 286 |
adipose | 46% | 32.79 | 559 / 1204 | 0% | 0 | 0 / 0 |
uterus | 38% | 7.63 | 64 / 170 | 7% | 3.30 | 32 / 459 |
ovary | 37% | 12.06 | 66 / 180 | 7% | 0.89 | 32 / 430 |
breast | 40% | 20.63 | 184 / 459 | 1% | 0.06 | 11 / 1118 |
lung | 37% | 163.80 | 214 / 578 | 4% | 0.43 | 42 / 1155 |
liver | 31% | 6.99 | 70 / 226 | 9% | 0.71 | 37 / 406 |
muscle | 40% | 10.75 | 319 / 803 | 0% | 0 | 0 / 0 |
intestine | 37% | 8.95 | 354 / 966 | 2% | 0.09 | 11 / 527 |
pancreas | 32% | 7.82 | 106 / 328 | 6% | 0.22 | 11 / 178 |
thymus | 38% | 14.26 | 246 / 653 | 1% | 0.01 | 4 / 605 |
esophagus | 35% | 8.47 | 501 / 1445 | 3% | 0.20 | 5 / 183 |
skin | 35% | 8.98 | 626 / 1809 | 1% | 0.01 | 4 / 472 |
kidney | 30% | 5.51 | 27 / 89 | 3% | 0.14 | 27 / 901 |
prostate | 33% | 15.24 | 81 / 245 | 0% | 0.00 | 1 / 502 |
bladder | 19% | 2.24 | 4 / 21 | 6% | 0.29 | 28 / 504 |
peripheral blood | 24% | 6.92 | 226 / 929 | 0% | 0 | 0 / 0 |
spleen | 24% | 3.88 | 57 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019934 | Biological process | cGMP-mediated signaling |
GO_0003161 | Biological process | cardiac conduction system development |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0006182 | Biological process | cGMP biosynthetic process |
GO_0043114 | Biological process | regulation of vascular permeability |
GO_0008217 | Biological process | regulation of blood pressure |
GO_0097746 | Biological process | blood vessel diameter maintenance |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0007168 | Biological process | receptor guanylyl cyclase signaling pathway |
GO_0003085 | Biological process | negative regulation of systemic arterial blood pressure |
GO_0007589 | Biological process | body fluid secretion |
GO_0006457 | Biological process | protein folding |
GO_0035815 | Biological process | positive regulation of renal sodium excretion |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0042311 | Biological process | vasodilation |
GO_0035810 | Biological process | positive regulation of urine volume |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005179 | Molecular function | hormone activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0008613 | Molecular function | diuretic hormone activity |
GO_0051427 | Molecular function | hormone receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NPPB |
Protein name | Natriuretic peptides B (Brain natriuretic factor prohormone) (preproBNP) (proBNP) (Gamma-brain natriuretic peptide) (Iso-ANP) [Cleaved into: NT-proBNP (NT-pro-BNP) (NT-proBNP(1-76)); proBNP(3-108); Brain natriuretic peptide 32 (BNP(1-32)) (BNP-32) (Brain natriuretic peptide) (BNP); BNP(1-30); BNP(1-29); BNP(1-28); BNP(2-31); BNP(3-32) (des-SerPro-BNP) (proBNP(79-108)); BNP(3-30); BNP(3-29); Brain natriuretic peptide 29 (BNP(4-32)); BNP(4-31); BNP(4-30); BNP(4-29); BNP(4-27); BNP(5-32); BNP(5-31); BNP(5-29)] |
Synonyms | |
Description | FUNCTION: [Brain natriuretic peptide 32]: Cardiac hormone that plays a key role in mediating cardio-renal homeostasis . May also function as a paracrine antifibrotic factor in the heart (By similarity). Acts by specifically binding and stimulating NPR1 to produce cGMP, which in turn activates effector proteins that drive various biological responses . Involved in regulating the extracellular fluid volume and maintaining the fluid-electrolyte balance through natriuresis, diuresis, vasorelaxation, and inhibition of renin and aldosterone secretion . Binds the clearance receptor NPR3 . .; FUNCTION: [NT-proBNP]: May affect cardio-renal homeostasis . Able to promote the production of cGMP although its potency is very low compared to brain natriuretic peptide 32 . .; FUNCTION: [BNP(3-32)]: May have a role in cardio-renal homeostasis . Able to promote the production of cGMP . . |
Accessions | P16860 ENST00000376468.4 |